NTHI · NeOnc Technologies Holdings Inc
United States · RS rating 28 · As of 2026-11-03
| Price | 3.07 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 72 / 41 / 13 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 9 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -52.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +74.0% |
| Market cap (USD) | $117.9M |